Please login to read the full article.
Scrip Regulatory Affairs
Companion diagnostics activity shines new light on the in vitro tests sector - is it all good?
17 November 2011
Ashley Yeo
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- US FDA sets 30 June deadline for finalising companion diagnostics guidance; publishes other device priorities
- Change of speed for medtech in China as SFDA looks to US regulatory model
- US to fortify "Common Rule" to improve study participant safety, oversight
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
